NCT04881240: Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia |
|
|
| Recruiting | 1 | 60 | US | CD19-CAR(Mem) T-cells, Cyclophosphamide, Cytoxan, Fludarabine, Fludara, Mesna, Mesnex, CliniMACS, Leukapheresis | St. Jude Children's Research Hospital | Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL | 06/26 | 06/27 | | |
